New antiepileptic drugs: Into the new millennium

Archives of Family Medicine

Volumn 9, Issue 10, 2000, Pages 1135-1141

  Tatum IV, W O ^a   Galvez, R ^a   Benbadis, S ^a   Carrazana, E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ZONISAMIDE;

ADULT; ANTICONVULSANT THERAPY; APLASTIC ANEMIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; LIVER FAILURE; MAJOR CLINICAL STUDY; NEUROTOXICITY; REVIEW; SEIZURE;

EID: 0034546527     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.9.10.1135     Document Type: Review

References (44)

1. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980
2. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)
3. Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel-group study
4. Gabapentin monotherapy, I: An 8-day, double-blind, dose-controlled, multi-center study in hospitalized patients with refractory complex partial or secondarily generalized seizures
5. Gabapentin monotherapy, II: A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures
6. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
7. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder
8. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures
9. Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, crossover trial
10. The Lamictal Lennox-Gastaut Study Group: Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome
11. An active-control trial of lamotrigine monotherapy for partial seizures
12. Lamotrigine in absence and primary generalized epilepsies
13. Lamotrigine can remove the pain associated with painful diabetic neuropathy
14. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar 1 depression
15. Long-term safety and efficacy of lamotrigine (Lamictal) in pediatric patients with epilepsy
16. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, 600-mg daily dosages
17. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
18. A double-blind, randomized trial of topiramate as adjunctive therapy for partial onset seizures in children
19. Topiramate monotherapy for partial onset seizures
20. Topiramate as add-on therapy in generalized seizures of non-focal origin
21. Topiramate
22. The role of complex combination therapy in the treatment of refractory bipolar illness
23. Topiramate treated cluster headaches
24. Postmarketing experience with topiramate and cognition
25. Tiagabine for complex partial seizures: A randomized, add-on, dose-response trial
26. Tiagabine therapy for complex partial seizures
27. Open-label dosage and tolerability study of tiagabine monotherapy in patients with refractory complex partial seizures
28. Pooled efficacy and safety data of levetiracetam used as adjunctive therapy in patients with partial onset seizures
29. Evidence for a unique profile of leviteracetam in rodent models of seizures and epilepsy
30. Oxcarbazepine: Current status and clinical applications
31. Oxcarbazepine
32. Zonisamide
33. Progressive myoclonus epilepsy treated with zonisamide
34. Intravenous administration of fosphenytoin: Options for the management of seizures
35. Intramuscular use of fosphenytoin: An overview
36. Efficacy and adverse effects of established and new antiepileptic drugs
37. The treatment of epilepsy: An overview of clinical practices
38. Antiepileptic drugs
39. Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy
40. Exacerbation of seizures in children by carbamazepine
41. Gabapentin treatment of seizures in acute intermittent porphyria